Report Categories
View AllRecent Articles
View All
Xenon Pharmaceuticals XENE Unveils Robust Azetukalner Phase III Data Q3 NDA Filing Plans at Bloom Burton Conference
GOODN Gladstone delivers 51 percent Q4 2025 EPS beat shares rise modestly on upbeat investor reaction
How transparent is Xcel XELLL financial reporting Xcel posts near inline EPS with 02 minor miss
The growth trajectory BlackRock Tech BSTZ is on and where it leads Rallies 20260503